Search research articles
Contact Us
Filters
Showing results (21-30 of 42) with videos related to
Page
of 5
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
July 19, 2005
Use of concomitant medication with antipsychotic treatment in outpatients with schizophrenia: results from the European Schizophrenia Outpatients Health Outcomes (SOHO) study
Diego Novick, Manuel Bousono, David Suarez, et al.
Psychiatry Research
|
February 4, 2018
Clinically significant personality traits in individuals at high risk of developing psychosis
Julia Sevilla-Llewellyn-Jones, Gustavo Camino, Debra A Russo, et al.
Journal of Clinical Medicine
|
November 27, 2021
Frequency of Iatrogenic Sexual Dysfunction Associated with Antihypertensive Compounds
Bárbara Buch-Vicente, José Mª Acosta, José-Angel Martín-Oterino, et al.
The Journal of Sexual Medicine
|
March 11, 2010
Frequency of sexual dysfunction in patients with a psychotic disorder receiving antipsychotics
Angel L Montejo, Susana Majadas, Fernando Rico-Villademoros, et al.
Primary Care Companion to the Journal of Clinical Psychiatry
|
January 26, 2010
"Caseness" for depression and anxiety in a depressed outpatient population: symptomatic outcome as a function of baseline diagnostic categories
Koen Demyttenaere, Anne Verhaeghen, Nicolas Dantchev, et al.
International Journal of Psychiatry in Clinical Practice
|
November 30, 2011
Treatment-emergent sexual dysfunction with SSRIs and duloxetine: effectiveness and functional outcomes over a 6-month observational period
Héctor Dueñas, Alan J M Brnabic, Arier Lee, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
April 4, 2006
Duloxetine in the prevention of relapse of major depressive disorder: double-blind placebo-controlled study
David G Perahia, Inmaculada Gilaberte, Fujun Wang, et al.
Journal of Clinical Medicine
|
January 23, 2024
Switching to Vortioxetine in Patients with Poorly Tolerated Antidepressant-Related Sexual Dysfunction in Clinical Practice: A 3-Month Prospective Real-Life Study
Angel L Montejo, Froilán Sánchez-Sánchez, Rubén De Alarcón, et al.
The Journal of Clinical Psychiatry
|
July 20, 2006
Consensus statement and research needs: the role of dopamine and norepinephrine in depression and antidepressant treatment
David J Nutt, David S Baldwin, Anita H Clayton, et al.
Frontiers in Public Health
|
September 19, 2024
Study protocol of a proposed Neurofeedback-Assisted Mindfulness Training Program on symptoms of anxiety and psychological distress associated with smartphone use in young adults: a randomized controlled trial
Mei Fernandez-Crespo, Jose I Recio-Rodriguez, Hsin-Chien Lee, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 42) with videos related to
Sort By:
Page
of 5
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
July 19, 2005
Use of concomitant medication with antipsychotic treatment in outpatients with schizophrenia: results from the European Schizophrenia Outpatients Health Outcomes (SOHO) study
Diego Novick, Manuel Bousono, David Suarez, et al.
Psychiatry Research
|
February 4, 2018
Clinically significant personality traits in individuals at high risk of developing psychosis
Julia Sevilla-Llewellyn-Jones, Gustavo Camino, Debra A Russo, et al.
Journal of Clinical Medicine
|
November 27, 2021
Frequency of Iatrogenic Sexual Dysfunction Associated with Antihypertensive Compounds
Bárbara Buch-Vicente, José Mª Acosta, José-Angel Martín-Oterino, et al.
The Journal of Sexual Medicine
|
March 11, 2010
Frequency of sexual dysfunction in patients with a psychotic disorder receiving antipsychotics
Angel L Montejo, Susana Majadas, Fernando Rico-Villademoros, et al.
Primary Care Companion to the Journal of Clinical Psychiatry
|
January 26, 2010
"Caseness" for depression and anxiety in a depressed outpatient population: symptomatic outcome as a function of baseline diagnostic categories
Koen Demyttenaere, Anne Verhaeghen, Nicolas Dantchev, et al.
International Journal of Psychiatry in Clinical Practice
|
November 30, 2011
Treatment-emergent sexual dysfunction with SSRIs and duloxetine: effectiveness and functional outcomes over a 6-month observational period
Héctor Dueñas, Alan J M Brnabic, Arier Lee, et al.
The British Journal of Psychiatry : the Journal of Mental Science
|
April 4, 2006
Duloxetine in the prevention of relapse of major depressive disorder: double-blind placebo-controlled study
David G Perahia, Inmaculada Gilaberte, Fujun Wang, et al.
Journal of Clinical Medicine
|
January 23, 2024
Switching to Vortioxetine in Patients with Poorly Tolerated Antidepressant-Related Sexual Dysfunction in Clinical Practice: A 3-Month Prospective Real-Life Study
Angel L Montejo, Froilán Sánchez-Sánchez, Rubén De Alarcón, et al.
The Journal of Clinical Psychiatry
|
July 20, 2006
Consensus statement and research needs: the role of dopamine and norepinephrine in depression and antidepressant treatment
David J Nutt, David S Baldwin, Anita H Clayton, et al.
Frontiers in Public Health
|
September 19, 2024
Study protocol of a proposed Neurofeedback-Assisted Mindfulness Training Program on symptoms of anxiety and psychological distress associated with smartphone use in young adults: a randomized controlled trial
Mei Fernandez-Crespo, Jose I Recio-Rodriguez, Hsin-Chien Lee, et al.
Page
of 5